royal-peptides.com
OFFICIAL ROYAL PEPTIDES WEBSITE You are on royal-peptides.com
VERIFY OFFICIAL SITE

Royal Peptides

ROYAL RESEARCH CATALOG

Semax 10mg

Research Material Batch Documentation Secure Checkout
Price range: $65 through $430
Choose an option
Clear selection
BUY MORE • SAVE MORE Volume Pricing
Standard pricing
10+Shop Kits10-vial kits →
01Research focusedLaboratory research materials
02DocumentedAvailable batch information
03TrackedOrder fulfillment updates
Secure payment VISA link $
RESEARCH NOTICE
For laboratory and research purposes only.Not intended for human consumption, diagnostic use, therapeutic use, or administration to humans or animals.
View Documentation →
Research Material • Semax

Semax Peptide Research Material

Semax is a synthetic heptapeptide research material structurally related to a fragment of adrenocorticotropic hormone (ACTH). It is investigated in controlled experimental systems involving peptide signaling, molecular interactions, gene-expression pathways, and neurobiological research models.

Semax Heptapeptide ACTH-Fragment Derived Lyophilized Material Batch Traceability
Research Use Only

Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use.

01
Compound Profile

Semax Research Material

Semax is a synthetic peptide composed of seven amino-acid residues. Its sequence incorporates an ACTH-derived peptide fragment together with a C-terminal Pro-Gly-Pro sequence, providing a defined molecular structure for experimental peptide research.

Scientific literature has examined Semax in laboratory and preclinical models involving molecular signaling, peptide interactions, transcriptional responses, and neurobiological pathways.

Royal Peptides supplies Semax strictly as a laboratory research material. References to published areas of investigation describe scientific context only and do not represent intended therapeutic or clinical uses of this product.

02
Molecular Identification

Defined Heptapeptide Sequence

Semax has a defined seven-residue peptide sequence. Its established molecular identity allows researchers to incorporate a specific, traceable peptide material into controlled analytical and experimental workflows.

Compound Semax Research peptide
Classification Heptapeptide Seven amino-acid residues
Sequence Met-Glu-His-Phe-Pro-Gly-Pro Defined synthetic sequence
Material Format Lyophilized Laboratory research material
03
Structural Context

ACTH-Fragment Derived Research Peptide

Semax is structurally associated with the ACTH(4–7) peptide fragment and incorporates a Pro-Gly-Pro sequence at its C-terminal region. This defined architecture provides a basis for comparative peptide and structure-function investigations.

Defined Seven-Residue Structure

The established sequence provides a specific molecular identity for analytical characterization and controlled laboratory investigation.

ACTH-Fragment Relationship

Semax contains a sequence structurally associated with the ACTH(4–7) fragment, providing a defined context for comparative peptide research.

Pro-Gly-Pro Sequence

A Pro-Gly-Pro sequence forms the C-terminal portion of Semax and contributes to its defined seven-residue molecular identity.

Structure-Function Research

Controlled models may compare peptide sequence, molecular structure, analytical characteristics, and experimentally measurable variables.

04
Scientific Context

Controlled Semax Research

Published experimental literature involving Semax spans several molecular and neurobiological research areas. These areas describe experimental investigation rather than intended uses of the research material supplied on this page.

Peptide Signaling Research

Experimental systems may examine Semax in relation to peptide-associated signaling pathways and measurable molecular responses.

Gene-Expression Research

Experimental models have investigated changes in molecular and transcriptional variables associated with Semax under defined research conditions.

Neurobiological Models

Semax appears in laboratory and preclinical literature involving neurobiological pathways and experimentally measurable molecular variables.

Molecular Interaction Studies

Controlled experimental systems may be used to investigate interactions between Semax and selected molecular pathways or biological research targets.

05
Analytical Documentation

Batch-Specific Research Information

Laboratory evaluation should rely on analytical documentation associated with the specific Semax production lot under investigation. General product-page information should not replace applicable batch-specific analytical records.

  • Compound identification
  • Production lot or batch reference
  • Declared material quantity
  • Analytical testing information
  • Purity information where applicable
  • Testing methodology where documented
  • Certificate of Analysis information where available
  • Research material traceability
06
Traceability

Research Records & Lot Control

Appropriate laboratory records help maintain traceability between experimental observations and the specific Semax production lot incorporated into a research workflow.

Material Identification

Record the Semax identity, stated material quantity, applicable production lot or batch reference, date received, and relevant internal laboratory identifier.

Analytical Records

Preserve applicable analytical documentation, experimental observations, results, storage records, and other research records associated with the material.

07
Laboratory Protocol

Handling & Storage

Semax research material should be handled using appropriate laboratory procedures designed to preserve material identity, minimize contamination, and maintain experimental traceability.

Professional Laboratory Handling

Handle using appropriate laboratory practices and equipment. Maintain clear material identification throughout receipt, storage, analytical preparation, and experimental workflows.

Storage & Records

Follow storage information associated with the applicable product label and batch documentation. Maintain appropriate laboratory storage and material-control records.

08
Important Restrictions

Research Use Limitations

Royal Peptides Semax is supplied exclusively as a laboratory research material. It is not offered or represented as a medicine, pharmaceutical preparation, dietary supplement, food, cosmetic, or consumer health product.

  • Not for human administration
  • Not for veterinary administration
  • Not for ingestion or injection
  • Not for personal experimentation
  • Not for pharmaceutical compounding
  • Not for pharmacy preparation
  • Not for diagnostic or therapeutic use
  • Not for clinical use
09
Research FAQ

Semax Research Questions

What is Semax?

Semax is a synthetic seven-amino-acid peptide structurally related to an ACTH-derived peptide fragment. Royal Peptides supplies it strictly as a laboratory research material.

How many amino acids are in Semax?

Semax contains seven amino-acid residues and is therefore classified as a heptapeptide.

What is the Semax peptide sequence?

Semax is commonly identified by the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Researchers should rely on documentation corresponding to the specific production lot being evaluated.

How is Semax related to ACTH?

Semax incorporates a peptide sequence structurally associated with the ACTH(4–7) fragment together with a Pro-Gly-Pro sequence. This relationship provides molecular context for laboratory peptide research.

What research areas involve Semax?

Published experimental research involving Semax includes peptide signaling, molecular interactions, gene-expression pathways, and neurobiological research models. These are scientific research contexts, not intended uses of this product.

How is Semax different from Selank?

Semax and Selank are separate synthetic heptapeptides with different amino-acid sequences and structural origins. Researchers should treat them as distinct materials and maintain separate compound and batch records.

Is Semax intended for human use?

No. Royal Peptides supplies Semax strictly for laboratory research. It is not intended for human or veterinary administration.

Does Royal Peptides provide dosing or administration instructions?

No. Royal Peptides does not provide dosing, administration, injection, prescribing, treatment, or personal-use instructions for Semax.

Why is the production lot important?

Batch-specific analytical documentation corresponds to a particular production lot. Recording the applicable lot reference supports traceability between the research material, analytical documentation, and laboratory records.

Is analytical documentation available?

Batch-specific analytical documentation may be available for the applicable production lot. Researchers should review documentation corresponding to the specific material received.

Research Use Only

Laboratory Research Material

Semax is supplied for laboratory research use only. Not for human or veterinary use. Not intended for administration, ingestion, injection, personal experimentation, pharmaceutical compounding, pharmacy preparation, diagnostic use, therapeutic use, or clinical use. Nothing on this page constitutes medical advice or represents this research material as intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

0